HALOZYME THERAPEUTICS, INC.
HALO
42 insider filings · Latest: Oct 6, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Sep 18, 2024 | Sep 18 8:01 PM | MICHAEL LABARRE | Proposed Sale | 10,000 | $62.03 | $620.3K | — | View → |
| Sep 17, 2024 | Sep 17 8:03 PM | MICHAEL LABARRE | Proposed Sale | 10,000 | $62.88 | $628.8K | — | View → |
| Sep 12, 2024 | Sep 12 8:12 PM | HELEN TORLEY | Proposed Sale | 10,000 | $59.20 | $592.0K | — | View → |
| Sep 11, 2024 | Sep 11 8:05 PM | HELEN TORLEY | Proposed Sale | 10,000 | $59.09 | $590.9K | — | View → |
| Sep 10, 2024 | Sep 10 8:16 PM | HELEN TORLEY | Proposed Sale | 10,000 | $59.09 | $590.9K | — | View → |
← Previous
Page 4 of 4
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Feb 20, 2026 | Feb 24 11:16 PM | Mark Howard SnyderSVP, CHIEF LEGAL OFFICER | Option Exercise | 5,332 | $0.00 | 15,995(D) | View → |
| Feb 23, 2026 | Feb 24 11:14 PM | Nicole LabrosseSVP, CHIEF FINANCIAL OFFICER | Option Exercise | 6,688 | $0.00 | 36,357(D) | View → |
| Feb 20, 2026 | Feb 24 11:14 PM | Nicole LabrosseSVP, CHIEF FINANCIAL OFFICER | Option Exercise | 5,332 | $0.00 | 15,995(D) | View → |
| Feb 23, 2026 | Feb 24 11:12 PM | Helen TorleyDirector, PRESIDENT AND CEO | Option Exercise | 22,436 | $0.00 | 44,872(D) | View → |
| Feb 20, 2026 | Feb 24 11:12 PM | Helen TorleyDirector, PRESIDENT AND CEO | Option Exercise | 16,757 | $0.00 | 50,270(D) | View → |
| Feb 16, 2026 | Feb 17 11:53 PM | Mark Howard SnyderSVP, CHIEF LEGAL OFFICER | Option Exercise | 16,812 | $0.00 | 0(D) | View → |
| Feb 16, 2026 | Feb 17 11:52 PM | Nicole LabrosseSVP, CHIEF FINANCIAL OFFICER | Option Exercise | 23,773 | $0.00 | 0(D) | View → |
| Feb 16, 2026 | Feb 17 11:51 PM | Helen TorleyDirector, PRESIDENT AND CEO | Option Exercise | 89,055 | $0.00 | 0(D) | View → |
| Feb 9, 2026 | Feb 12 2:21 AM | Cortney CaudillSVP, CHIEF OPERATING OFFICER | Grant/Award | 44,248 | $80.48 | 14,751(D) | View → |
| Feb 9, 2026 | Feb 12 2:20 AM | Mark Howard SnyderSVP, CHIEF LEGAL OFFICER | Grant/Award | 78,087 | $80.48 | 29,502(D) | View → |
| Feb 9, 2026 | Feb 12 2:20 AM | Nicole LabrosseSVP, CHIEF FINANCIAL OFFICER | Grant/Award | 42,117 | $0.00 | 29,502(D) | View → |
| Feb 9, 2026 | Feb 12 1:56 AM | Helen TorleyDirector, PRESIDENT AND CEO | Grant/Award | 241,366 | $80.48 | 92,714(D) | View → |
| Feb 5, 2026 | Feb 6 12:38 AM | Helen TorleyDirector, PRESIDENT AND CEO | Option Exercise | 10,000 | $12.07 | 201,923(D) | View → |
| Feb 4, 2026 | Feb 6 12:38 AM | Helen TorleyDirector, PRESIDENT AND CEO | Option Exercise | 20,000 | $12.07 | 211,923(D) | View → |
| Feb 3, 2026 | Feb 6 12:38 AM | Helen TorleyDirector, PRESIDENT AND CEO | Option Exercise | 20,000 | $12.07 | 231,923(D) | View → |
← Previous
Page 3 of 3